IWel Health Inc. develops and markets advanced biosensing platform technology including continuous glucose monitoring (CGM) technology. Our facility is located in a beautiful corporate park in Exton, PA.
Glucose monitoring is extremely crucial for diabetic patients. However, the traditional finger-pricking method is not only painful, and inconvenient but also has limited clinical value due to its single-point reading. More and more patients including most of Type I patients have transitioned to the new CGM technology due to its significant clinical benefits. It has shown that application of CGM technology not only leads a much better treatment regimen from treating doctors and also reduces adverse events due to its trigger and alert functions as a result of continuous monitoring.
IWel CGM technology provides continuous real-time glucose readings and alerts with its disposable, easy to use, ultra compact device at affordable cost. The readings are directly displayed on a mobile phone or smartwatch, no need for scanner or another receiver.
Application of our CGM is currently focused on metabolic health coaching and management including Type 2 diabetes, prediabetes and weight loss.